Diana Zuckerman is president of the National Center for Health Research, a nonprofit think tank based in Washington, D.C.
Diana Zuckerman
President
National Center for Health Research
From this contributor
How the new U.S. ‘Right to Try’ law could harm people with autism
People with autism already have access to experimental treatments; the new law could make that access more dangerous.
How the new U.S. ‘Right to Try’ law could harm people with autism
Why the 21st Century Cures Act could be disastrous for medicine
A new bill threatens to lower the scientific standards that have made the Food and Drug Administration's approval the gold standard worldwide.
Why the 21st Century Cures Act could be disastrous for medicine
Explore more from The Transmitter
How insights from network theory can boost interdisciplinary efforts
Communication on one interdisciplinary research team improved after the researchers turned an analysis technique used to study the brain on themselves and identified the roles people played in lab meetings.
How insights from network theory can boost interdisciplinary efforts
Communication on one interdisciplinary research team improved after the researchers turned an analysis technique used to study the brain on themselves and identified the roles people played in lab meetings.
Frameshift: Raphe Bernier followed his heart out of academia, then made his way back again
After a clinical research career, an interlude at Apple and four months in early retirement, Raphe Bernier found joy in teaching.
Frameshift: Raphe Bernier followed his heart out of academia, then made his way back again
After a clinical research career, an interlude at Apple and four months in early retirement, Raphe Bernier found joy in teaching.
Organoid study reveals shared brain pathways across autism-linked variants
The genetic variants initially affect brain development in unique ways, but over time they converge on common molecular pathways.
Organoid study reveals shared brain pathways across autism-linked variants
The genetic variants initially affect brain development in unique ways, but over time they converge on common molecular pathways.